EULAR efforts to define quality of care

Clinical and Experimental Rheumatology

Volumn 25, Issue 6 SUPPL. 47, 2007, Pages

  Dougados, Maxime ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

EULAR; Quality of care quality indicators; Recommendations

Indexed keywords

ARTICLE; COOPERATION; DATA COLLECTION METHOD; DOCTOR PATIENT RELATION; EDUCATION PROGRAM; EUROPE; EVIDENCE BASED MEDICINE; HEALTH CARE MANAGEMENT; HEALTH CARE MANPOWER; HEALTH CARE PLANNING; HEALTH CARE QUALITY; INFORMATION DISSEMINATION; MEDICAL PRACTICE; MEDICAL RECORD; MEDICAL RESEARCH; MEDICAL SPECIALIST; MUSCULOSKELETAL DISEASE; OUTCOMES RESEARCH; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EUROPE; GUIDELINE ADHERENCE; HUMANS; QUALITY INDICATORS, HEALTH CARE; QUALITY OF HEALTH CARE; SOCIETIES;

EID: 36448987200     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. FRIES JF, SPITZ P, KRAINES RG, HOLMAN HR: Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 137-45.
2. GROL R, GRIMSHAW J: From best evidence to best practice: Effective implementation of change in patients' care. Lancet 2003: 362: 1225-30.
3. GALLAGHER EJ: Evolution of Academic Emergency Medicine over a decade (1991-2001). Acad Emerg Med 2002; 9: 995-1000.
4. CAMINITI C, SCODITTI U, DIODATI F, PASSALACQUA R: How to promote, improve and test adherence to scientific evidence in clinical practice. BMC Health Serv Res 2005, 5: 62.
5. FECHTENBAUM J, LECOQ D'ANDRÉ F, NATAF H et al.: Practice patterns in outpatient rheumatology: A pilot evaluation of medical file content. Joint Bone Spine 2007; 74: 171-4.
6. AVOUAC J, GOSSEC L, DOUGADOS M: Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: A systematic literature review. Ann Rheum Dis 2006; 65: 845-51.
7. COMBE B, LANDEWE R, LUKAS C et al.: EULAR recommendations for the management of early arthritis: Report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007; 66: 34-45.
8. ZOCHLING J, VAN DER HEIJDE D, DOUGADOS M, BRAUN J: Current evidence for the management of ankylosing spondylitis: A systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis. Ann Rheum Dis 2006; 65: 423-32.
9. GOSSEC L, KVIEN TK, PHILLIPS C et al.: Dissemination and evaluation of the ASAS/EULAR recommendations for the management of ankylosing spondylitis: Results of a study among 1507 rheumatologists. Ann Rheum Dis 2007; 66 (Suppl. 2): 65.
10. ZOCHLING J, VAN DER HEIJDE D, BURGOS-VARGAS R et al.: ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 2006; 65: 442-52.
11. DOUGADOS M, BETTERIDGE N, BURMESTER GR et al.: EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees. Ann Rheum Dis 2004; 63: 1172-6.
12. JORDAN KM, ARDEN NK, DOHERTY M et al.: EULAR Recommendations 2003: An evidence based approach to the management of knee osteoarthritis: Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003; 62: 1145-55.
13. PENDLETON A, ARDEN N, DOUGADOS M et al.: EULAR recommendations for the management of knee osteoarthritis: Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2000; 59: 936-44.
14. ZHANG W, DOHERTY M, ARDEN N et al.: EULAR evidence-based recommendations for the management of hip osteoarthritis: Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2005; 64: 669-81.
15. ZHANG W, DOHERTY M, PASCUAL E et al.: EULAR evidence-based recommendations for gout. Part I. Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006; 65: 1301-11.
16. ZHANG W, DOHERTY M, BARDIN T et al.: EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006; 65: 1312-24.
17. WALKER UA, TYNDALL A, CZIRJAK L et al.: Clinical risk assessment of organ manifestations in systemic sclerosis - A report from the EULAR Scleroderma Trials and Research (EUSTAR) group data base. Ann Rheum Dis 2007; 66: 754-63.
18. ZHANG W, DOHERTY M, LEEB BF et al.: EULAR evidence-based recommendations for the management of hand osteoarthritis: Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007; 66: 377-88.
19. HELLMICH B, FLOSSMAN O, GROSS WL et al.: EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: Focus on ANCA-associated vasculitis. Ann Rheum Dis 2007; 66: 605-17.
20. www.eular-onlinecourse.org
21. SOKKA T, MÄKINEN H, KAUTIAINEN H et al.: Disease activity of patients with rheumatoid arthritis (RA) seen in standard rheumatology care in 20 countries in the Quest-RA study. Ann Rheum Dis 2007; 66 (Suppl. 2): 337.